Literature DB >> 11481484

Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

A Loonstra1, M Vooijs, H B Beverloo, B A Allak, E van Drunen, R Kanaar, A Berns, J Jonkers.   

Abstract

The use of Cre/loxP recombination in mammalian cells has expanded rapidly. We describe here that Cre expression in cultured mammalian cells may result in a markedly reduced proliferation and that this effect is dependent on the endonuclease activity of Cre. Chromosome analysis after Cre expression revealed numerous chromosomal aberrations and an increased number of sister chromatid exchanges. Titration experiments in mouse embryo fibroblasts with a ligand-regulatable Cre-ER(T) show that toxicity is dependent on the level of Cre activity. Prolonged, low levels of Cre activity permit recombination without concomitant toxicity. This urges for a careful titration of Cre activity in conditional gene modification in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481484      PMCID: PMC55399          DOI: 10.1073/pnas.161269798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  DNA specificity of the Cre recombinase resides in the 25 kDa carboxyl domain of the protein.

Authors:  R Hoess; K Abremski; S Irwin; M Kendall; A Mack
Journal:  J Mol Biol       Date:  1990-12-20       Impact factor: 5.469

2.  Simplified mammalian DNA isolation procedure.

Authors:  P W Laird; A Zijderveld; K Linders; M A Rudnicki; R Jaenisch; A Berns
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

3.  Mammalian genomes contain active recombinase recognition sites.

Authors:  B Thyagarajan; M J Guimarães; A C Groth; M P Calos
Journal:  Gene       Date:  2000-02-22       Impact factor: 3.688

4.  The role of the loxP spacer region in P1 site-specific recombination.

Authors:  R H Hoess; A Wierzbicki; K Abremski
Journal:  Nucleic Acids Res       Date:  1986-03-11       Impact factor: 16.971

5.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1.

Authors:  B Sauer; N Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Bacteriophage P1 Cre-loxP site-specific recombination. Site-specific DNA topoisomerase activity of the Cre recombination protein.

Authors:  K Abremski; A Wierzbicki; B Frommer; R H Hoess
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

7.  Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids.

Authors:  E E Schmidt; D S Taylor; J R Prigge; S Barnett; M R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

8.  Properties of a mutant Cre protein that alters the topological linkage of recombination products.

Authors:  K Abremski; B Frommer; A Wierzbicki; R H Hoess
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

9.  A mutational analysis of the bacteriophage P1 recombinase Cre.

Authors:  A Wierzbicki; M Kendall; K Abremski; R Hoess
Journal:  J Mol Biol       Date:  1987-06-20       Impact factor: 5.469

10.  The integrase family of site-specific recombinases: regional similarities and global diversity.

Authors:  P Argos; A Landy; K Abremski; J B Egan; E Haggard-Ljungquist; R H Hoess; M L Kahn; B Kalionis; S V Narayana; L S Pierson
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  229 in total

1.  Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells.

Authors:  Susanne Andreas; Frieder Schwenk; Birgit Küter-Luks; Nicole Faust; Ralf Kühn
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

Review 2.  Cre/lox: one more step in the taming of the genome.

Authors:  Brian Sauer
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  Cre recombinase expression can result in phenotypic aberrations in plants.

Authors:  Eric R Coppoolse; Marianne J de Vroomen; Dick Roelofs; Jaap Smit; Femke van Gennip; Bart J M Hersmus; H John J Nijkamp; Mark J J van Haaren
Journal:  Plant Mol Biol       Date:  2003-01       Impact factor: 4.076

4.  RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells.

Authors:  Yukiko M Yamashita; Takashi Okada; Takahiro Matsusaka; Eiichiro Sonoda; Guang Yu Zhao; Kasumi Araki; Satoshi Tateishi; Masaru Yamaizumi; Shunichi Takeda
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

5.  Stable and efficient cassette exchange under non-selectable conditions by combined use of two site-specific recombinases.

Authors:  Matthias Lauth; Fabio Spreafico; Kathrin Dethleffsen; Michael Meyer
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

6.  An Lck-cre transgene accelerates autoantibody production and lupus development in (NZB × NZW)F1 mice.

Authors:  R K Nelson; K A Gould
Journal:  Lupus       Date:  2015-09-18       Impact factor: 2.911

Review 7.  Tracking cells in their native habitat: lineage tracing in epithelial neoplasia.

Authors:  Maria P Alcolea; Philip H Jones
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

8.  Cre recombinase induces DNA damage and tetraploidy in the absence of loxP sites.

Authors:  Vaibhao C Janbandhu; Daniel Moik; Reinhard Fässler
Journal:  Cell Cycle       Date:  2013-11-26       Impact factor: 4.534

9.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

10.  Hypomorphic mutation in an essential cell-cycle kinase causes growth retardation and impaired spermatogenesis.

Authors:  Jung Min Kim; Naofumi Takemoto; Ken-ichi Arai; Hisao Masai
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.